{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T17:56:33Z","timestamp":1771264593628,"version":"3.50.1"},"reference-count":24,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2012,12,1]],"date-time":"2012-12-01T00:00:00Z","timestamp":1354320000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The American Journal of Cardiology"],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1016\/j.amjcard.2012.07.026","type":"journal-article","created":{"date-parts":[[2012,8,31]],"date-time":"2012-08-31T03:20:01Z","timestamp":1346383201000},"page":"1623-1626","source":"Crossref","is-referenced-by-count":37,"title":["Capecitabine-Induced Chest Pain Relieved by Diltiazem"],"prefix":"10.1016","volume":"110","author":[{"given":"Andrew P.","family":"Ambrosy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pamela L.","family":"Kunz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George A.","family":"Fisher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ronald M.","family":"Witteles","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"suppl","key":"10.1016\/j.amjcard.2012.07.026_bib1","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0959-8049(01)00414-2","article-title":"Rational development of capecitabine","volume":"38","author":"Venturini","year":"2002","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.amjcard.2012.07.026_bib2","doi-asserted-by":"crossref","first-page":"2282","DOI":"10.1200\/JCO.2001.19.8.2282","article-title":"Comparison of oral capecitabine versus intravenous fluorouracil plus leucovorin as first-line treatment in 605 patients with metastatic colorectal cancer: results of a randomized phase III study","volume":"19","author":"Hoff","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.amjcard.2012.07.026_bib3","doi-asserted-by":"crossref","first-page":"4097","DOI":"10.1200\/JCO.2001.19.21.4097","article-title":"Oral capecitabine compared with intravenous fluorouracil plus leucovorin in patients with metastatic colorectal cancer: results of a large phase III study","volume":"19","author":"Van Cutsem","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.amjcard.2012.07.026_bib4","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1200\/JCO.2000.18.6.1337","article-title":"Capecitabine, an oral fluoropyrimidine carbamate with substantial activity in advanced colorectal cancer: results of a randomized phase II study","volume":"18","author":"Van Cutsem","year":"2000","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.amjcard.2012.07.026_bib5","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1023\/A:1012281104865","article-title":"Randomized, open-label, phase II trial of oral capecitabine (Xeloda) vs. a reference arm of intravenous CMF (cyclophosphamide, methotrexate and 5-fluorouracil) as first-line therapy for advanced\/metastatic breast cancer","volume":"12","author":"Oshaughnessy","year":"2001","journal-title":"Ann Oncol"},{"key":"10.1016\/j.amjcard.2012.07.026_bib6","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1093\/annonc\/mdf089","article-title":"First-line oral capecitabine therapy in metastatic colorectal cancer: a favorable safety profile compared with intravenous 5-fluorouracil\/leucovorin","volume":"13","author":"Cassidy","year":"2002","journal-title":"Ann Oncol"},{"key":"10.1016\/j.amjcard.2012.07.026_bib7","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1093\/annonc\/mdg500","article-title":"Oral capecitabine as an alternative to i.v. 5-fluorouracil-based adjuvant therapy for colon cancer: safety results of a randomized, phase III trial","volume":"14","author":"Scheithauer","year":"2003","journal-title":"Ann Oncol"},{"key":"10.1016\/j.amjcard.2012.07.026_bib8","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1038\/sj.bjc.6603049","article-title":"A phase II study of fixed-dose capecitabine and assessment of predictors of toxicity in patients with advanced\/metastatic colorectal cancer","volume":"94","author":"Sharma","year":"2006","journal-title":"Br J Cancer"},{"key":"10.1016\/j.amjcard.2012.07.026_bib9","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1200\/JCO.1999.17.2.485","article-title":"Multicenter phase II study of capecitabine in paclitaxel-refractory metastatic breast cancer","volume":"17","author":"Blum","year":"1999","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.amjcard.2012.07.026_bib10","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1023\/A:1011152931300","article-title":"Coronary spasm induced by capecitabine","volume":"12","author":"Schnetzler","year":"2001","journal-title":"Ann Oncol"},{"key":"10.1016\/j.amjcard.2012.07.026_bib11","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1093\/annonc\/mdf035","article-title":"Capecitabine can induce acute coronary syndrome similar to 5-fluorouracil","volume":"13","author":"Frickhofen","year":"2002","journal-title":"Ann Oncol"},{"key":"10.1016\/j.amjcard.2012.07.026_bib12","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1177\/000331970405500114","article-title":"Capecitabine-induced coronary vasospasm\u2014a case report","volume":"55","author":"Rizvi","year":"2004","journal-title":"Angiology"},{"key":"10.1016\/j.amjcard.2012.07.026_bib13","doi-asserted-by":"crossref","first-page":"494","DOI":"10.7326\/0003-4819-140-6-200403160-00034","article-title":"Capecitabine induces severe angina-like chest pain","volume":"140","author":"Kuppens","year":"2004","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.amjcard.2012.07.026_bib14","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1345\/aph.1E252","article-title":"Common etiology of capecitabine and fluorouracil-induced coronary vasospasm in a colon cancer patient","volume":"39","author":"Aksoy","year":"2005","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.amjcard.2012.07.026_bib15","doi-asserted-by":"crossref","first-page":"136","DOI":"10.2459\/01.JCM.0000199785.94760.50","article-title":"Coronary artery spasm induced by capecitabine","volume":"7","author":"Sestito","year":"2006","journal-title":"J Cardiovasc Med (Hagerstown)"},{"key":"10.1016\/j.amjcard.2012.07.026_bib16","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1136\/emj.2007.055681","article-title":"Capecitabine-associated coronary vasospasm: a case report","volume":"25","author":"Papadopoulos","year":"2008","journal-title":"Emerg Med J"},{"key":"10.1016\/j.amjcard.2012.07.026_bib17","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.3748\/wjg.v13.i14.2135","article-title":"A case of capecitabine-induced coronary microspasm in a patient with rectal cancer","volume":"13","author":"Arbea","year":"2007","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.amjcard.2012.07.026_bib18","doi-asserted-by":"crossref","first-page":"3802","DOI":"10.1200\/JCO.2008.17.1637","article-title":"Capecitabine-induced coronary vasospasm","volume":"26","author":"Goldsmith","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.amjcard.2012.07.026_bib19","doi-asserted-by":"crossref","first-page":"e34","DOI":"10.1016\/j.ijcard.2007.06.152","article-title":"Capecitabine induced vasospastic angina","volume":"130","author":"Coughlin","year":"2008","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.amjcard.2012.07.026_bib20","doi-asserted-by":"crossref","first-page":"722","DOI":"10.2459\/JCM.0b013e32832bb9b1","article-title":"Capecitabine-induced cardiotoxicity: when to suspect?","volume":"10","author":"Farina","year":"2009","journal-title":"J Cardiovasc Med (Hagerstown)"},{"key":"10.1016\/j.amjcard.2012.07.026_bib21","doi-asserted-by":"crossref","first-page":"700","DOI":"10.2459\/JCM.0b013e328332e873","article-title":"Capecitabine cardiac toxicity presenting as effort angina: a case report","volume":"11","author":"Lestuzzi","year":"2010","journal-title":"J Cardiovasc Med (Hagerstown)"},{"key":"10.1016\/j.amjcard.2012.07.026_bib22","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1111\/j.1445-5994.2009.02144.x","article-title":"Cardiotoxicity with 5-fluorouracil and capecitabine: more than just vasospastic angina","volume":"40","author":"Stewart","year":"2010","journal-title":"Intern Med J"},{"key":"10.1016\/j.amjcard.2012.07.026_bib23","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1159\/000227226","article-title":"Symptomatic cardiotoxicity with high-dose 5-fluorouracil infusion: a prospective study","volume":"50","author":"Akhtar","year":"1993","journal-title":"Oncology"},{"key":"10.1016\/j.amjcard.2012.07.026_bib24","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1093\/annonc\/mdh150","article-title":"5-Fluorouracil induces arterial vasocontractions","volume":"15","author":"Sudhoff","year":"2004","journal-title":"Ann Oncol"}],"container-title":["The American Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914912018474?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914912018474?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,21]],"date-time":"2018-11-21T04:59:36Z","timestamp":1542776376000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002914912018474"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,12]]},"references-count":24,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["S0002914912018474"],"URL":"https:\/\/doi.org\/10.1016\/j.amjcard.2012.07.026","relation":{},"ISSN":["0002-9149"],"issn-type":[{"value":"0002-9149","type":"print"}],"subject":[],"published":{"date-parts":[[2012,12]]}}}